RightFit
RecruitingNot applicable

AVI Didactic Experience for Latinx Patient Treatment Adherence and Non-English Speaker Trial Enrollment Study in Rad Onc

Audiovisual Didactic Experience for Latinx Patient Treatment Adherence and Non-English Speaker Trial Enrollment (ADELANTE) Study in Radiation Oncology

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
18 Years and older
Sex
All sexes
Healthy volunteers
Not accepted
Compensation
Not stated

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

Not stated in the study description — ask the study team about visits and procedures.

Compensation
Not stated
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

In plain language

This study develops educational media for Spanish-speaking Latinx patients with breast or prostate cancer. It aims to help them prepare for radiation treatment and make informed choices about joining cancer clinical trials.

The study aims to develop educational media interventions to prepare Latinx Spanish-speaking radiation oncology patients for a course of breast or prostate cancer radiation therapy and to foster receptivity and informed decision-making around cancer clinical trial participation.

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Who can join

  • Both phases: Speak Spanish and have Mexican, Puerto Rican, Cuban, Dominican, Central American, or South American ancestry.
  • Pilot phase: Are being treated for breast or prostate cancer, or were recently treated.
  • Main study: Have breast or prostate cancer confirmed by a tissue test that has not spread to distant parts of the body.
  • Main study: Have a health history review and physical exam within 28 days before joining.
  • Main study: Have a Karnofsky score of at least 70, meaning you can care for yourself but may not be able to do normal activities or work.
  • Main study: Women who could become pregnant must have pregnancy testing under the study center’s rules.
  • Main study: Plan to have radiation meant to cure the cancer. If chemotherapy or hormone treatment comes first, you may join at a follow-up visit.
  • Main study: Have a certified interpreter at the consultation visit.

Who can't join

  • Both phases: Are deaf in both ears or blind.
  • Both phases: Have psychosis, which can make it hard to know what is real, or dementia, which affects memory and thinking.
  • Main study: Exams or scans show cancer has spread to distant parts of the body.
  • Main study: Have taken part in a cancer patient education study before.
  • Main study: Have had radiation treatment before.
  • Main study: Are getting radiation to a body area other than the breast or prostate.

Simplified for readability. The official criteria below are what the study team uses.

Official eligibility criteria

Pilot Phase Inclusion Criteria: 1. Spanish speakers of Latinx background as defined by the U.S. Census Bureau as anyone from Mexican, Puerto Rican, Cuban, Dominican, Central or South American ancestry 2. Currently undergoing treatment for breast or prostate cancer, or recently been treated Pilot Phase Exclusion Criteria: 1. Patient with bilateral deafness and/or blindness 2. Patient with psychosis and/or dementia Main Study Inclusion Criteria: 1. Spanish speakers of Latinx background as defined by the U.S. Census Bureau as anyone from Mexican, Puerto Rican, Cuban, Dominican, Central or South American ancestry 2. Patients with non-metastatic prostate or breast cancer 3. Histopathologically proven diagnosis of prostate or breast cancer 4. History and physical examination within 28 days prior to enrollment 5. Karnofsky performance status 70 or greater 6. For women of childbearing potential, pregnancy testing to be performed in accordance to institutional guidelines 7. Plan to receive definitive, curative radiation. Patients planning to receive curative RT after upcoming adjuvant chemotherapy or induction hormonal therapy may enroll at reconsult "follow-up" visit. 8. Consultation visit must be performed with a certified interpreter Main Study Exclusion Criteria: 1. Patient with bilateral deafness and/or blindness 2. Patient with psychosis and/or dementia 3. Clinical or radiological evidence of metastatic disease 4. Prior participation in cancer patient education trial 5. Prior RT 6. RT for sites other than breast or prostate

Study sites (2)

FL

NY